Compounds > aspirin

aspirin and l 365260

aspirin has been researched along with l 365260 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barreto, JC; Cross, JM; Mercer, DW; Miller, TA; Russell, DH; Strobel, NH1
Ewing, RW; Fitzpatrick, LR; Martin, GE; Molino, BF; Pendley, CE1

Other Studies

2 other study(ies) available for aspirin and l 365260

ArticleYear
Cholecystokinin is a potent protective agent against alcohol-induced gastric injury in the rat. Role of endogenous prostaglandins.
    Digestive diseases and sciences, 1995, Volume: 40, Issue:3

    Topics: Animals; Aspirin; Benzodiazepinones; Cholecystokinin; Devazepide; Ethanol; Female; Gastric Mucosa; Indomethacin; Phenylurea Compounds; Premedication; Prostaglandins; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin A; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Sincalide

1995
The gastrin/cholecystokinin-B receptor antagonist L-365,260 reduces basal acid secretion and prevents gastrointestinal damage induced by aspirin, ethanol and cysteamine in the rat.
    The Journal of pharmacology and experimental therapeutics, 1993, Volume: 265, Issue:3

    Topics: Animals; Aspirin; Benzodiazepinones; Cysteamine; Digestive System; Dose-Response Relationship, Drug; Ethanol; Gastric Acid; Guinea Pigs; In Vitro Techniques; Male; Phenylurea Compounds; Rats; Rats, Sprague-Dawley; Receptors, Cholecystokinin

1993